Wink Biotherapeutics

Wink Biotherapeutics

Private
Hallandale Beach, FloridaHealthcare & Life Scienceshttps://winkbiotx.com/

Last Round

Pre Seed

May 19, 2025

Total Funding Raised

$105,000

Company Overview

Wink Biotherapeutics is a drug discovery company that develops a proprietary RNA aptamer technology with precise targeting of disease mechanisms for patients with autoimmune and oncologic conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

RNA aptamersType 1 DiabetesT1DRNA therapeuticsbeta cell regenerationcurative treatmentdisease-modifying therapyaptamer technologybeta cell protectionpreclinical biotechtargeted drug deliverysolid tumor therapeuticsoncology platforminjectable therapeuticsuniversity spinoff

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wink Biotherapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Wink Biotherapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMay 19, 2025
GrantDec 9, 2024
AcceleratorJul 6, 2023

Key People

Founding team and executive leadership

Warren D. Marcus

Co-Founder CEO

Founding Team

Wink Biotherapeutics Investors

Notable investors and investment history

InvestorRounds
Dreamward VenturesPre Seed
Venture BlackPre Seed
Venture BlackPre Seed
BioFlorida, Inc.Grant
StartUp HealthPre Seed, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors grew 446% MoM, reaching 1.4K.

  • May 19, 2025

    $75K raised from StartUp Health and Dreamward Ventures.

Wink Biotherapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wink Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wink Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHallandale Beach, Florida
Employee Range5
Year Founded2020
Last FundingMay 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.